Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.041 | 0.7 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.056 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |